Myricetin inhibits panel of kinases implicated in tumorigenesis
Stefani Stoll1, Shanna Bitencourt1, Stefan Laufer2
1Cell Culture Laboratory, Postgraduate Program in Biotechnology, University of Taquari Valley (Univates), Lajeado, Brazil.
Abstract:
Myricetin is a flavonoid with several biological properties, including antioxidant and anti-inflammatory features. Its protective effect in chronic diseases may occur through the inhibition of protein kinases that trigger inflammation and carcinogenesis pathways. Considering the influence of kinases on such pathological disorders, it is crucial to study compounds that inhibit these proteins. This study aims to evaluate the inhibitory potential of 14 flavonoids on TNF-α release in human whole blood as well as the inhibitory potential of myricetin towards kinases involved in tumorigenesis. Our results showed that, out of all flavonoids, myricetin had the highest inhibitory effect on TNF-α level. In addition, myricetin showed potential as a multi-anti-kinase compound, reducing the activity of 7 kinases by >70% and of 9 kinases by >90%. Together these data demonstrate the great inhibitory activity of myricetin on tumorigenic kinases and potential for the development of new therapeutics.
Insights
Myricetin, a flavonoid, effectively inhibits tumor necrosis factor-alpha (TNF-α) release and multiple cancer-related kinases. This suggests myricetin
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Myricetin is a flavonoid with known antioxidant and anti-inflammatory properties.
- Protein kinases play crucial roles in inflammation and carcinogenesis pathways.
- Inhibiting these kinases is a key strategy for managing chronic diseases and cancer.
Purpose of the Study:
- To evaluate the potential of 14 flavonoids in inhibiting TNF-α release.
- To assess the inhibitory effects of myricetin on specific kinases involved in tumorigenesis.
Main Methods:
- In vitro screening of 14 flavonoids for TNF-α inhibition in human whole blood.
- Assay of myricetin's inhibitory activity against a panel of tumorigenesis-related kinases.
Main Results:
- Myricetin demonstrated the most potent inhibition of TNF-α release among all tested flavonoids.
- Myricetin exhibited multi-kinase inhibitory activity, reducing 7 kinases by over 70% and 9 kinases by over 90%.
Conclusions:
- Myricetin possesses significant inhibitory effects on TNF-α and multiple tumorigenic kinases.
- These findings highlight myricetin's therapeutic potential for developing novel anti-cancer agents.
More Related Videos
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Wood Panel Products
Feedback Inhibition
Receptor Tyrosine Kinases
Enzyme Inhibition


